OpenLegislation

Division 5.8.1 Instructions concerning specific positionsF1

United Kingdom

Original text. Later amendments are not shown.

Columns
010

Exposure value

Article 271 CRR in conjunction with Article 382 CRR.

Total EAD from all transactions subject to CVA charge.

020

Of which: OTC derivatives

Article 271 CRR in conjunction with Article 382(1) CRR.

The part of the total counterparty credit risk exposure solely due to OTC derivatives. The information is not required from IMM institutions holding OTC derivatives and SFTs in the same netting set.

030

Of which: SFT

Article 271 CRR in conjunction with Article 382(2) CRR

The part of the total counterparty credit risk exposure solely due to SFT derivatives. The information is not required from IMM institutions holding OTC derivatives and SFTs in the same netting set.

040

MULTIPLICATION FACTOR (mc) x AVERAGE OF PREVIOUS 60 WORKING DAYS (VaRavg)

Article 383 CRR in conjunction with point (d) of Article 363(1) CRR.

VaR calculation based on internal models for market risk

050

PREVIOUS DAY (VaRt-1)

See instructions for column 040.

060

MULTIPLICATION FACTOR (ms) x AVERAGE OF PREVIOUS 60 WORKING DAYS (SVaRavg)

See instructions for column 040

070

LATEST AVAILABLE (SVaRt-1)

See instructions for column 040

080

OWN FUNDS REQUIREMENTS

Point (d) of Article 92(3) CRR.

Own funds requirements for CVA Risk calculated via the chosen method.

090

TOTAL RISK EXPOSURE AMOUNT

Point (b) of Article 92(4) CRR.

Own funds requirements multiplied by 12,5 .

Memorandum items

100

Number of counterparties

Article 382 CRR

Number of counterparties included in calculation of own funds for CVA risk.

Counterparties are a subset of obligors. They only exist in case of derivatives transactions or SFTs where they are the other contracting party.

110

Of which: proxy was used to determine credit spread

Number of counterparties where the credit spread was determined using a proxy instead of directly observed market data.

120

INCURRED CVA

Accounting provisions due to decreased credit worthiness of derivatives counterparties.

130

SINGLE NAME CDS

Point (a) of Article 386(1) CRR

Total notional amounts of single name CDS used as hedge for CVA risk.

140

INDEX CDS

Point (b) of Article 386(1) CRR

Total notional amounts of index CDS used as hedge for CVA risk.

Rows
010

CVA risk total

Sum of rows 020-040

020

Advanced method

Advanced CVA risk method as prescribed by Article 383 CRR

030

Standardised method

Standardised CVA risk method as prescribed by Article 384 CRR

040

Based on OEM

Amounts subject to the application of Article 385 CRR

Annotations

Textual amendments

F1

Substituted by Commission Implementing Regulation (EU) 2020/429 of 14 February 2020 amending Implementing Regulation (EU) No 680/2014 laying down implementing technical standards with regard to supervisory reporting of institutions according to Regulation (EU) No 575/2013 of the European Parliament and of the Council (Text with EEA relevance).